BBOT
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Open
15 Dec, 19:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 16
-0.43
-3.42%
$
- Market Cap
- P/E Ratio
- Div Yield
64,980 Volume
- Eps
$ 12.59
Previous Close Day Range
12 12.73
Year Range
8.5 14.87
Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 58 days
BBOT have yet to publish their earning reports.
BBOT Earnings Reports FAQ
What is the earnings per share (EPS) for BBOT?
EPS data for BBOT is currently not available, as BridgeBio Oncology Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
BridgeBio Oncology Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-11, based on the BBOT's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BridgeBio Oncology Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BBOT at this time, as BridgeBio Oncology Therapeutics, Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
